Back to top

Stoke Therapeutics (STOK) Receives a Buy from Jefferies

In a report released today, from Jefferies maintained a Buy rating on Stoke Therapeutics, with a price target of $48.00. Currently, the analyst con...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Stoke Therapeutics, Inc. (STOK)